GSK-CureVac's 2nd Covid vaccine shows better immune response

CV2CoV has higher neutralising capacity against a range of variants, including the Beta, Delta and Lambda variant and the original virus strain, the company said in a statement on Monday.

from Zee News :Zee News - Health https://ift.tt/3yWzqNs
via IFTTT